Company Profile
CEO
Ms. Birgit Girshick(CEO & Director)
Sector
Healthcare
Industry
Diagnostics & Research
Employees
18.3K
Beta
1.45
Forward P/E
14.7
52W High
$228.88
52W Low
$140.78
Profit Margin
-4.6%
Operating Margin
15.9%
Return on Equity
-5.9%
Revenue Growth
1.2%
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mi...
Valuation
Market Cap$8.97B
P/E (TTM)--
P/S (TTM)2.25
EV/EBITDA13.91
Cash Flow
FCF Yield-0.7%
SBC Adj. FCF Yield-1.7%
SBC Impact150.9%
Margins & Growth
Profit Margin-1.5%
Operating Margin12.0%
Revenue YoY1.2%
Earnings YoY--
Balance
Cash$191.83M
Debt$1.63B
Net Cash$-1.43B
Dividend
Dividend Yield--
Payout Ratio--
Quarterly Payout--